Provided by Tiger Fintech (Singapore) Pte. Ltd.

Annexon, Inc.

2.45
+0.05002.08%
Post-market: 2.520.0700+2.86%19:54 EDT
Volume:863.63K
Turnover:2.07M
Market Cap:268.80M
PE:-2.10
High:2.47
Open:2.35
Low:2.29
Close:2.40
Loading ...

Annexon Inc - Topline Phase 3 Data Expected in Second Half of 2026

THOMSON REUTERS
·
24 Jul

Annexon Announces Completion of Enrollment in Pivotal Phase 3 Archer Ii Trial of Vonaprument (Formerly Anx007) for Dry Age-Related Macular Degeneration (Amd) With Geographic Atrophy

THOMSON REUTERS
·
24 Jul

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

GlobeNewswire
·
24 Jul

Ted Yednock, EVP & Chief Innovation Officer, Reports Disposal of Annexon Inc. Common Shares

Reuters
·
17 Jul

Annexon tells Wells Fargo doctor tweet not factural

TIPRANKS
·
11 Jul

Annexon Up Over 18%, on Pace For Highest Close Since February -- Data Talk

Dow Jones
·
03 Jul

Annexon Inc. Unveils Visionary Plan to Revolutionize Treatment for Complement-Mediated Diseases

Reuters
·
25 Jun

BRIEF-Annexon says enrollment of Phase 3 Archer II Trial expected to be completed in Q3 2025

Reuters
·
19 Jun

Annexon Inc. Strengthens Ophthalmology Team with Appointment of Dr. Lloyd Clark as Senior VP to Lead Pivotal ANX007 Program in AMD Treatment

Reuters
·
19 Jun

Annexon Biosciences Holds Annual Stockholders Meeting

TIPRANKS
·
10 Jun

Annexon Inc. Concluded Annual Stockholders Meeting

Reuters
·
10 Jun

Annexon Inc. Announces CEO Douglas Love to Present at Jefferies Global Healthcare Conference

Reuters
·
30 May

Annexon presents tanruprubart data at PNS annual meeting

TIPRANKS
·
20 May

BRIEF-Annexon Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
17 May

Annexon Inc. Announces Inducement Grants for New Employees Under 2022 Employment Inducement Award Plan

Reuters
·
17 May

Annexon price target lowered to $14 from $20 at H.C. Wainwright

TIPRANKS
·
13 May

Annexon Is Maintained at Buy by Needham

Dow Jones
·
13 May

Annexon Biosciences Reports Increased Q1 2025 Losses

TIPRANKS
·
13 May

TD Cowen Sticks to Its Buy Rating for Annexon Biosciences (ANNX)

TIPRANKS
·
13 May

Annexon Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
12 May